- Home
- SOS vs ERNA Comparison
SOS vs ERNA Comparison
Compare SOS & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOS
- ERNA
- Stock Information
- Founded
- SOS 2004
- ERNA 2018
- Country
- SOS China
- ERNA United States
- Employees
- SOS N/A
- ERNA N/A
- Industry
- SOS Finance: Consumer Services
- ERNA Biotechnology: Pharmaceutical Preparations
- Sector
- SOS Finance
- ERNA Health Care
- Exchange
- SOS Nasdaq
- ERNA Nasdaq
- Market Cap
- SOS 10.7M
- ERNA 10.2M
- IPO Year
- SOS 2017
- ERNA N/A
- Fundamental
- Price
- SOS $1.84
- ERNA $1.29
- Analyst Decision
- SOS
- ERNA
- Analyst Count
- SOS 0
- ERNA 0
- Target Price
- SOS N/A
- ERNA N/A
- AVG Volume (30 Days)
- SOS 1.6M
- ERNA 79.4K
- Earning Date
- SOS 09-24-2025
- ERNA 11-11-2025
- Dividend Yield
- SOS N/A
- ERNA N/A
- EPS Growth
- SOS N/A
- ERNA N/A
- EPS
- SOS N/A
- ERNA N/A
- Revenue
- SOS $231,424,000.00
- ERNA $488,000.00
- Revenue This Year
- SOS N/A
- ERNA N/A
- Revenue Next Year
- SOS N/A
- ERNA N/A
- P/E Ratio
- SOS N/A
- ERNA N/A
- Revenue Growth
- SOS 150.42
- ERNA 201.24
- 52 Week Low
- SOS $1.18
- ERNA $1.19
- 52 Week High
- SOS $2.04
- ERNA $23.70
- Technical
- Relative Strength Index (RSI)
- SOS 42.85
- ERNA 37.60
- Support Level
- SOS $1.02
- ERNA $1.19
- Resistance Level
- SOS $2.04
- ERNA $1.57
- Average True Range (ATR)
- SOS 0.28
- ERNA 0.14
- MACD
- SOS 0.20
- ERNA 0.01
- Stochastic Oscillator
- SOS 79.90
- ERNA 26.32
About SOS SOS Limited
SOS Ltd is a multifaceted company that leverages the power of data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other services. The company has three reporting segments: Commodity trading, Cryptocurrency mining, and Others. Key revenue is generated from Commodity trading.
About ERNA Eterna Therapeutics Inc.
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.